BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 38770019)

  • 1.
    Sadeghi M; Haghshenas B; Nami Y
    Front Microbiol; 2024; 15():1396308. PubMed ID: 38770019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Modulation Capability of Exopolysaccharides Synthesised by Lactic Acid Bacteria and Bifidobacteria.
    Hidalgo-Cantabrana C; López P; Gueimonde M; de Los Reyes-Gavilán CG; Suárez A; Margolles A; Ruas-Madiedo P
    Probiotics Antimicrob Proteins; 2012 Dec; 4(4):227-37. PubMed ID: 26782182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bifidobacteria-produced exopolysaccharides on human gut microbiota in vitro.
    Liu G; Chen H; Chen J; Wang X; Gu Q; Yin Y
    Appl Microbiol Biotechnol; 2019 Feb; 103(4):1693-1702. PubMed ID: 30569218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the biological activities of microbial exopolysaccharides.
    Salimi F; Farrokh P
    World J Microbiol Biotechnol; 2023 May; 39(8):213. PubMed ID: 37256348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activities and applications of exopolysaccharides produced by lactic acid bacteria: a mini-review.
    Yang Y; Jiang G; Tian Y
    World J Microbiol Biotechnol; 2023 Apr; 39(6):155. PubMed ID: 37039945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review of anticancer, immunomodulatory and health beneficial effects of the lactic acid bacteria exopolysaccharides.
    Rahbar Saadat Y; Yari Khosroushahi A; Pourghassem Gargari B
    Carbohydr Polym; 2019 Aug; 217():79-89. PubMed ID: 31079688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Therapeutic Potentials of Exopolysaccharides Derived From Lactic Acid Bacteria and Bifidobacteria: Antioxidant, Antitumor, and Periodontal Regeneration.
    Khalil MA; Sonbol FI; Al-Madboly LA; Aboshady TA; Alqurashi AS; Ali SS
    Front Microbiol; 2022; 13():803688. PubMed ID: 35547125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifidobacteria in Fermented Dairy Foods: A Health Beneficial Outlook.
    Jena R; Choudhury PK
    Probiotics Antimicrob Proteins; 2023 Nov; ():. PubMed ID: 37979040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial exopolysaccharides: Unveiling the pharmacological aspects for therapeutic advancements.
    Akhtar N; Wani AK; Sharma NR; Sanami S; Kaleem S; Machfud M; Purbiati T; Sugiono S; Djumali D; Retnaning Prahardini PE; Purwati RD; Supriadi K; Rahayu F
    Carbohydr Res; 2024 May; 539():109118. PubMed ID: 38643705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactic acid bacteria-derived exopolysaccharide: Formation, immunomodulatory ability, health effects, and structure-function relationship.
    Zhang J; Xiao Y; Wang H; Zhang H; Chen W; Lu W
    Microbiol Res; 2023 Sep; 274():127432. PubMed ID: 37320895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifidobacteria cell wall-derived exo-polysaccharides, lipoteichoic acids, peptidoglycans, polar lipids and proteins - their chemical structure and biological attributes.
    Pyclik M; Srutkova D; Schwarzer M; Górska S
    Int J Biol Macromol; 2020 Mar; 147():333-349. PubMed ID: 31899242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel exopolysaccharide derived from probiotic
    Sheng S; Fu Y; Pan N; Zhang H; Xiu L; Liang Y; Liu Y; Liu B; Ma C; Du R; Wang X
    Front Microbiol; 2022; 13():1015270. PubMed ID: 36225355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Genomic Diversity and Antimicrobial Susceptibility of Bifidobacterium pseudocatenulatum in a Vietnamese Population.
    Chung The H; Nguyen Ngoc Minh C; Tran Thi Hong C; Nguyen Thi Nguyen T; Pike LJ; Zellmer C; Pham Duc T; Tran TA; Ha Thanh T; Van MP; Thwaites GE; Rabaa MA; Hall LJ; Baker S
    Microbiol Spectr; 2021 Oct; 9(2):e0052621. PubMed ID: 34523984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exopolysaccharides from
    Tarique M; Ali AH; Kizhakkayil J; Liu SQ; Oz F; Dertli E; Kamal-Eldin A; Ayyash M
    Food Chem X; 2024 Mar; 21():101073. PubMed ID: 38235344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus.
    Ruas-Madiedo P; Gueimonde M; Margolles A; de los Reyes-Gavilán CG; Salminen S
    J Food Prot; 2006 Aug; 69(8):2011-5. PubMed ID: 16924934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and health-promoting properties of probiotics' exopolysaccharides; isolation, characterization, and applications in the food industry.
    Pourjafar H; Ansari F; Sadeghi A; Samakkhah SA; Jafari SM
    Crit Rev Food Sci Nutr; 2023; 63(26):8194-8225. PubMed ID: 35266799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial exopolysaccharides in the biomedical and pharmaceutical industries.
    Waoo AA; Singh S; Pandey A; Kant G; Choure K; Amesho KTT; Srivastava S
    Heliyon; 2023 Aug; 9(8):e18613. PubMed ID: 37593641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exopolysaccharides Produced by Lactic Acid Bacteria: From Biosynthesis to Health-Promoting Properties.
    Jurášková D; Ribeiro SC; Silva CCG
    Foods; 2022 Jan; 11(2):. PubMed ID: 35053888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugar-coated: exopolysaccharide producing lactic acid bacteria for food and human health applications.
    Ryan PM; Ross RP; Fitzgerald GF; Caplice NM; Stanton C
    Food Funct; 2015 Mar; 6(3):679-93. PubMed ID: 25580594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exopolysaccharides from probiotic bacteria and their health potential.
    Angelin J; Kavitha M
    Int J Biol Macromol; 2020 Nov; 162():853-865. PubMed ID: 32585269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.